Keep up to date on the latest medical news at MDLinx - FREE!

  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed

World’s Largest Physician Panel Formed As M3 USA Purchases EU-Based EMS Research

M3 GR logo web tag

M3 Global Research combines MDLinx and EMS to offer online access to 1.3 million healthcare professionals

Washington, DC, November 22, 2010 – M3 USA, parent company of MDLinx, a leading medical market research firm, has signed an agreement to purchase EU-based EMS Research, a company specializing in quantitative and qualitative market research for clients in healthcare and other vertical markets.

The acquisition creates the largest verified provider of physicians and other healthcare professionals in the world.  This new international division will be designated M3 Global Research.  With offices in the US, UK, Germany, Japan, Korea and China, M3 Global Research will offer access to 1.3 million verified doctors and other healthcare professionals, differentiated into more than 700 subspecialties.

M3 Global Research will provide the highest standard of direct access, utilizing its proprietary physician panels, online survey tools, call centers, fieldwork studios, and in-house project managers in offices around the world.

“EMS Research has always prided itself on our superior market research capabilities.  By teaming with M3, we have greatly expanded the depth and breadth of our abilities on a global perspective,” said Neil Jarvis, Director at EMS.

“Europe was the missing component in our market research global coverage strategy.  The EMS acquisition firmly secures our place as the healthcare market research industry leader, and equips us with the largest verified panel of healthcare professionals in the world,” said Aki Tomaru, CEO of M3 USA.  “Our clients will now enjoy unparalleled global reach as they gather insights from healthcare professionals and experience our best-in-industry, single source service.”

M3 Global Research and M3 USA

M3 Global Research is the market research division of Tokyo-based M3 Inc. (JP:2413) operating globally with a proprietary healthcare professional panel of 1.3 million  respondents in more than 60 countries.  The division was created by uniting the worldwide panels of MDLinx in the USA, EMS Research in Europe, and M3 companies across Asia.  M3 Global Research offers a broad range of capabilities including quantitative, qualitative, and omnibus surveys utilizing call centers and in-country project managers.  M3 has provided solutions for every top 20 pharmaceutical company in the world.  For more information, visit or email requests to

EMS Research

EMS Research, headquartered in London, England, was founded in 1999 and is Europe’s leading in-house medical fieldwork company.  M3 Global Research will maintain EMS’s unparalleled research quality at competitive cost via effective management and expansion of research assets across Europe,  including respondent databases, pan-European project teams, in-house moderators, online survey tools, call centers, field teams and viewing facilities.

Greg Jones for M3 Global Research

Trending Medical Articles

Tuesday, Apr 8, 2014
Journal of Medical Imaging and Radiation Oncology, 04/08/2014 Graham PH – The purpose of this study was to evaluate the cardiac dosimetry delivered before and after routine 3D CT whole–breast radiotherapy planning, including cardiac contouring and the relevance of a 15–mm maximum myocardial depth (MMD) planning tolerance threshold. Changes in cardiac dosimetry associated with...Read More
Monday, Mar 31, 2014
Nordic Journal of Psychiatry, 03/31/2014 Soderstrom S, et al. – The study aims to develop a Swedish Comprehensive International Classification of Functioning, Disability and Health (ICF) Core Set for adult patients with Attention–deficit hyperactivity disorder (ADHD). The Comprehensive Core Set for ADHD should be regarded as national and preliminary, and should be further tested...Read More
Wednesday, Apr 9, 2014
Pediatric Cardiology, 04/09/2014 Bockeria LA, et al. – Cardiopulmonary bypass (CPB) reduces coagulation factor levels through hemodilution and consumption. Differences in CPB–induced alterations of factor XIII (FXIII) levels in children with cyanotic and acyanotic congenital heart defects (CHDs) are not well characterized. The rational strategy of postoperative FXIII replacement...Read More
Wednesday, Mar 26, 2014
Journal of Clinical Pharmacy and Therapeutics, 03/26/2014 Zhu LQ, et al. – Drug–induced hepatotoxicity is potentially lethal. Liver transplant patients receive a large number of medications and adverse drug reactions, and drug–drug interactions must be closely monitored. Close monitoring and prompt discontinuation of the drugs with high volume of distribution and metabolized...Read More
Monday, Apr 7, 2014
International Journal of Surgical Pathology, 04/07/2014 Patriarca C, et al. – Twelve cases of urothelial cell papillary carcinoma with a whorled pattern of growth are described. All cases showed this peculiar and distinctive curlicue histological pattern, ranging from 50% to 100% of the neoplastic population. Despite the disordered/turbulent growth pattern, the cytological grade was...Read More